Zoetis Inc. (NYSE:ZTS) Shares Sold by Spire Wealth Management

Spire Wealth Management trimmed its holdings in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 35.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,298 shares of the company's stock after selling 5,744 shares during the quarter. Spire Wealth Management's holdings in Zoetis were worth $1,678,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of ZTS. Cherry Creek Investment Advisors Inc. raised its holdings in Zoetis by 2.0% in the 3rd quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company's stock worth $590,000 after purchasing an additional 58 shares during the period. Grove Bank & Trust boosted its stake in Zoetis by 0.5% during the 3rd quarter. Grove Bank & Trust now owns 11,763 shares of the company's stock worth $2,298,000 after purchasing an additional 61 shares during the last quarter. Hancock Whitney Corp lifted its stake in shares of Zoetis by 0.3% in the third quarter. Hancock Whitney Corp now owns 18,569 shares of the company's stock worth $3,628,000 after buying an additional 61 shares in the last quarter. Strategy Asset Managers LLC grew its stake in Zoetis by 3.5% during the 3rd quarter. Strategy Asset Managers LLC now owns 1,822 shares of the company's stock valued at $356,000 after acquiring an additional 62 shares in the last quarter. Finally, Procyon Advisors LLC lifted its stake in Zoetis by 1.4% in the 4th quarter. Procyon Advisors LLC now owns 4,712 shares of the company's stock worth $768,000 after purchasing an additional 63 shares in the last quarter. Institutional investors own 92.80% of the company's stock.

Wall Street Analyst Weigh In

ZTS has been the topic of a number of analyst reports. Leerink Partnrs upgraded Zoetis to a "strong-buy" rating in a research report on Monday, December 2nd. Morgan Stanley decreased their price objective on Zoetis from $248.00 to $243.00 and set an "overweight" rating on the stock in a report on Wednesday, January 29th. Leerink Partners began coverage on shares of Zoetis in a research report on Monday, December 2nd. They set an "outperform" rating and a $215.00 price target for the company. UBS Group started coverage on Zoetis in a report on Monday, December 9th. They issued a "neutral" rating and a $196.00 price objective on the stock. Finally, Stifel Nicolaus cut their price target on Zoetis from $210.00 to $180.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Zoetis has a consensus rating of "Buy" and a consensus target price of $215.00.

Zoetis Price Performance

Shares of ZTS traded up $0.30 during mid-day trading on Tuesday, reaching $172.24. 2,696,175 shares of the company's stock were exchanged, compared to its average volume of 2,685,644. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The company has a 50-day simple moving average of $169.48 and a two-hundred day simple moving average of $179.39. The company has a market cap of $77.71 billion, a price-to-earnings ratio of 32.38, a PEG ratio of 2.72 and a beta of 0.90. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion for the quarter, compared to analysts' expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. During the same period last year, the company earned $1.36 earnings per share. The company's quarterly revenue was up 11.6% on a year-over-year basis. On average, sell-side analysts predict that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This is an increase from Zoetis's previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a yield of 1.16%. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis's payout ratio is currently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.